Industry: Pharmaceuticals, Biotechnology
Molecular Insight Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics. The company’s product candidates target markets with significant unmet needs in cardiology, oncology, and neurology. Molecular Insight’s lead cardiology product candidate, Zemivaâ„¢ (iodofiltic acid I 123) is in development as a molecular imaging pharmaceutical for the diagnosis of insufficient blood flow to the heart, or cardiac ischemia. The company’s second lead product candidate, Azedraâ„¢, is in development for the diagnosis and treatment of neuroendocrine tumors. Molecular Insight Pharmaceuticals is based in Cambridge, Massachusetts. ( www.molecularinsight.com )
Molecular Insight Pharmaceuticals, Inc.
160 Second Street
Cambridge, Massachusetts 02142
USA
Tel: (617) 492-5554
Fax: (617) 492-5664